First Trust Mid Cap Value AlphaDEX Fund (NASDAQ:FNK) Increases Dividend to $0.20 Per Share

Key Points

• The First Trust Mid Cap Value AlphaDEX Fund (NASDAQ:FNK) has increased its quarterly dividend to $0.20 per share, representing a 3.4% rise from its previous dividend of $0.19.
• The ex-dividend date is set for Thursday, September 25th, with dividends payable on Tuesday, September 30th to stockholders of record.
• As of Thursday, FNK opened at $55.58, with a market cap of $202.87 million and a P/E ratio of 10.44.

First Trust Mid Cap Value AlphaDEX Fund (NASDAQ:FNK - Get Free Report) declared a quarterly dividend on Wednesday, September 24th. Stockholders of record on Thursday, September 25th will be given a dividend of 0.1979 per share on Tuesday, September 30th. This represents a c) dividend on an annualized basis and a dividend yield of 1.4%. The ex-dividend date of this dividend is Thursday, September 25th. This is a 3.4% increase from First Trust Mid Cap Value AlphaDEX Fund's previous quarterly dividend of $0.19.

First Trust Mid Cap Value AlphaDEX Fund Stock Performance

FNK opened at $55.58 on Thursday. First Trust Mid Cap Value AlphaDEX Fund has a one year low of $42.68 and a one year high of $58.52. The company has a market cap of $202.87 million, a P/E ratio of 10.44 and a beta of 1.29. The business's 50-day simple moving average is $54.59 and its 200-day simple moving average is $51.51.

About First Trust Mid Cap Value AlphaDEX Fund

The First Trust Mid Cap Value AlphaDEX Fund (FNK) is an exchange-traded fund that is based on the NASDAQ AlphaDEX Mid Cap Value index. The fund tracks a mid-cap index that selects value stocks using quant methodology and applies an equal-tiered weighting scheme. FNK was launched on Apr 18, 2011 and is managed by First Trust.

This instant news alert was generated by narrative science technology and financial data from MarketBeat in order to provide readers with the fastest and most accurate reporting. This story was reviewed by MarketBeat's editorial team prior to publication. Please send any questions or comments about this story to contact@marketbeat.com.